Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 62.86M P/E - EPS this Y 46.30% Ern Qtrly Grth -
Income -26.3M Forward P/E -2.58 EPS next Y 14.90% 50D Avg Chg -14.00%
Sales 895.48k PEG - EPS past 5Y - 200D Avg Chg -34.00%
Dividend N/A Price/Book 6.29 EPS next 5Y - 52W High Chg -63.00%
Recommedations 2.50 Quick Ratio 0.80 Shares Outstanding 21.89M 52W Low Chg 29.00%
Insider Own 21.63% ROA -93.42% Shares Float 18.39M Beta 0.12
Inst Own 0.47% ROE -303.20% Shares Shorted/Prior 720.64K/324.52K Price 4.11
Gross Margin 56.92% Profit Margin - Avg. Volume 25,011 Target Price 2.00
Oper. Margin -3,068.71% Earnings Date Oct 2 Volume 36,528 Change 0.49%
About Mainz Biomed N.V.

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.

Mainz Biomed N.V. News
11/13/24 The Oncology Bet Is Already Paying Off For Pfizer
11/12/24 Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
10/22/24 Mainz Biomed restructured operations, implemented cost reductions
07:01 AM Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
10/10/24 Mainz Biomed Secures Additional $1.5M Funding
10/08/24 Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
10/01/24 The Covid Era Tech Promises To Reinvent Cancer Treatment
10/01/24 Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
09/20/24 Pfizer Advances On Its Cancer Journey
09/18/24 Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
09/04/24 Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
07/30/24 Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
07/25/24 Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
07/10/24 Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test
07/09/24 Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
07/02/24 mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
07/02/24 Mainz Biomed Provides Half Year 2024 Corporate Update
06/04/24 Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
06/03/24 Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
05/31/24 Mainz Biomed Reports Results of 2024 Annual General Meeting
MYNZ Chatroom

User Image letsmakesomemoneytoday Posted - 59 minutes from now

$MYNZ run this up lets go. Lets get to .25 today

User Image peterb030 Posted - 35 minutes from now

$MYNZ jesus what are talking dumb, missed half off last news!

User Image Monogg Posted - 21 minutes from now

$MYNZ I see a short position when the split is announced, I hope it will reach 0.10, there is no bullish position here, don't kid yourself

User Image Monogg Posted - 18 minutes from now

$MYNZ Is it a 1/100 reverse split? 1/50? But first you need dilution, otherwise after splitting this garbage will return to the penny

User Image Rolanivy Posted - 4 minutes from now

$MYNZ 🫣is this 0 volume on my screen correct ?

User Image peterb030 Posted - 20 minutes ago

@Hankies a rs normally not good for the stockprice normally, but again $MYNZ is in a special position, everything is ready, all the people on the right spots....just waiting. 180 delay will pop the stockprice

User Image SERTX40 Posted - 20 minutes ago

$MYNZ is today the Day?

User Image Hoopdream Posted - 33 minutes ago

$MYNZ Have I understood correctly that Mainz Biomed strategically withdrew its BDD application this year to focus on expanding clinical data, with plans to submit to the FDA in 2025? I am bullish but we are not waiting for FDA approval so far, correct?

User Image Hankies Posted - 39 minutes ago

$MYNZ It's a critical decision for mgmt to make in relation to the RS. I have ever so rarely witnessed organic growth from this far from $1 to achieve compliance. The longer it sits at these levels the more it appears as a penny stock that tutes will stay away from. Another 180 of that doesn't help anyone's cause. If they have something brewing in the background short term for boosting investor confidence they better play that card sooner than later. Money talks on WS, period. Partnerships and FDA approvals are part of the process but not the end all of be all. Bio stocks are feast or famine and tough ones to predict.

User Image Dusty18184859 Posted - 48 minutes ago

$MYNZ buy the hype sell the news

User Image Allie_Vo Posted - 1 hour ago

@rustycat The most important is Advanced Adenoma before people step into the cancer patient category. MYNZ has an 88% detection rate, while all others are only approved once you already HAVE IT, which you would know anyway. So all this sensitivity that you mentioned for those who already have it. But none of EXAS or GH can confirm advanced adenoma in the pre-cancer stage. This is important!!! $MYNZ $EXAS $GH

User Image peterb030 Posted - 2 hours ago

$MYNZ a reverse split or a 180 delay its both no problem! $MYNZ has all the attention, the FDA will come with good news. The only thing for 👉 is to be on board on time cause after the good news you only can jump on the left train

User Image peterb030 Posted - 2 hours ago

$MYNZ before the 25th.....

User Image gino2222 Posted - 7 hours ago

$MYNZ I believe the company will receive the 180 days extension. There will be no reverse split That's my take ❗🧨⬆️ We will find out soon enough ❗

User Image Dusty18184859 Posted - 10 hours ago

$MYNZ junk

User Image 1KEI Posted - 11 hours ago

$MYNZ

User Image Hankies Posted - 11 hours ago

$MYNZ This is most entertaining to see how this responds to the hype and cross spamming. Unreal and shameless pumping, news out AH, partnerships coming (truth to a recent one anyway), blah, blah, blah. I will consider a few once below .20 for fun. Partnership for "research design" is a first step, but no money to be made for years. Deal with the RS and then see what investors come out. No point before then.

User Image silentfury Posted - 14 hours ago

$MYNZ this will up hard. $TMO running hard after hours. I feel this partnership will be epic. Just got to have patience.

User Image S_Franconi Posted - 14 hours ago

@GabriellePham I am blocking all the spammers from $MYNZ.

User Image Samuele_ Posted - 14 hours ago

$MYNZ that's it?!?!?!?

User Image 100zubide Posted - 15 hours ago

$MYNZ going north

User Image ChillOutbro Posted - 15 hours ago

$MYNZ or it’s great

User Image Turkey12 Posted - 15 hours ago

$MYNZ you know your fucked when 19 minutes after closing all you hear is crickets in a chat room lol

User Image grancougar Posted - 15 hours ago

$MYNZ Adding 28K 👍👍👍💪💪💪

User Image Turkey12 Posted - 15 hours ago

$MYNZ did yall just give up after hours or what

User Image gnarled15 Posted - 15 hours ago

$MYNZ the spam for this name is rude.

User Image M_Summers87 Posted - 15 hours ago

$MYNZ news out 🧐

User Image JadeHodge Posted - 15 hours ago

$MYNZ news drop in AH ?

User Image farcanal Posted - 15 hours ago

$MYNZ is fast becoming the most ticker-spammed stock on @Stocktwits. Somebody desperately underwater here with a bot farm to deploy?

User Image ReignCherry Posted - 15 hours ago

$MYNZ tomorrow might be nasdaq compliance news

Analyst Ratings
Cantor Fitzgerald Neutral Apr 12, 24
HC Wainwright & Co. Buy Mar 6, 24
Cantor Fitzgerald Neutral Nov 21, 23
HC Wainwright & Co. Buy Nov 20, 23
Cantor Fitzgerald Overweight Sep 26, 23
HC Wainwright & Co. Buy Sep 22, 23
Cantor Fitzgerald Overweight Sep 14, 23
Cantor Fitzgerald Overweight Aug 22, 23
HC Wainwright & Co. Buy Aug 18, 23